Ensysce Biosciences Net Debt Growth & History (ENSC)

Ensysce Biosciences's net debt was −$4.0M for fiscal 2025.

View full Ensysce Biosciences company overview

Ensysce Biosciences annual net debt history

Ensysce Biosciences annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$4.0M−$803,229
20242024-12-31−$3.2M−$2.9M
20232023-12-31−$268,907$2.9M
20222022-12-31−$3.1M$9.1M
20212021-12-31−$12.2M−$12.1M
20202020-12-31−$168,714

Ensysce Biosciences net debt trends

Over the last five fiscal years, Ensysce Biosciences's net debt decreased from −$168,714 to −$4.0M, a change of −$3.8M. The latest reported quarter, Q2 2026, shows −$479,862.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Ensysce Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about ENSC yet. Start the conversation.

Write the first post